Sun-Novo(SH:688621) Zheng Quan Zhi Xing·2025-06-11 10:28Core Viewpoint - The legal opinion from Beijing Tianyuan Law Firm confirms that Beijing Sunshine Nuohuo Pharmaceutical Research Co., Ltd. has complied with all necessary legal procedures for the initial grant of the 2025 restricted stock incentive plan [1][7]. Group 1: Legal Procedures - The initial grant of the incentive plan was approved by the company's board on May 12, 2025, and the relevant proposals were passed [3]. - The proposed incentive objects were publicly announced from May 13 to May 22, 2025, with no objections raised by employees [4]. - The second extraordinary general meeting of shareholders approved the incentive plan on May 28, 2025, and authorized the board to handle all necessary matters related to the grant [5]. Group 2: Grant Date and Conditions - The board determined the grant date for the incentive plan as June 11, 2025, which complies with relevant regulations [5][6]. - The conditions for granting the restricted stock include the absence of disqualifying circumstances as outlined in the management regulations [6]. - The company has verified that the initial grant of restricted stock to eligible incentive objects meets all legal and regulatory requirements [7].